ImaginAb Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ImaginAb Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10870
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product portfolio includes fungicides, herbicides, and insecticides among others. Biomar’s pharmaceutical preclinical pipeline comprises compounds for cancer, glioblastoma, and infectious and autoimmune diseases. The company also offers services such as taxonomical identification, screening and active compound identification. The company is funded by Cycad Group, Raptor, and Nextech Invest Ltd among others. It has operation in the US and Japan. ImaginAb is headquartered in Inglewood, California, the US.

ImaginAb Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImaginAb Inc, Medical Devices Deals, 2012 to YTD 2018 9
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImaginAb Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ImaginAb Raises USD7.7 Million in Venture Financing 11
ImaginAb Raises USD5.3 Million in Financing 12
ImaginAb Raises USD21 Million in Series B Venture Financing 13
Partnerships 14
Eli Lilly Enters into Research Agreement with ImaginAb 14
ImaginAb Enters Into Co-Development Agreement With H. Lundbeck For CNS Imaging Biologics 15
ImaginAb Inc – Key Competitors 16
ImaginAb Inc – Key Employees 17
ImaginAb Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jun 22, 2018: Imagin Reconstitutes Japanese Subsidiary 19
May 17, 2018: ImaginAb Reconstitutes Scientific Advisory Board 20
Feb 06, 2018: ImaginAb Names Ian Wilson As Chief Operating Officer 21
Mar 22, 2017: ImaginAb Appoints Martyn Coombs as New Chief Executive Officer 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
ImaginAb Inc, Pharmaceuticals & Healthcare, Key Facts 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Deals By Therapy Area, 2012 to YTD 2018 8
ImaginAb Inc, Medical Devices Deals, 2012 to YTD 2018 9
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImaginAb Raises USD7.7 Million in Venture Financing 11
ImaginAb Raises USD5.3 Million in Financing 12
ImaginAb Raises USD21 Million in Series B Venture Financing 13
Eli Lilly Enters into Research Agreement with ImaginAb 14
ImaginAb Enters Into Co-Development Agreement With H. Lundbeck For CNS Imaging Biologics 15
ImaginAb Inc, Key Competitors 16
ImaginAb Inc, Key Employees 17

List of Figures
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImaginAb Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ImaginAb Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Centrica Plc (CNA):企業の財務・戦略的SWOT分析
    Centrica Plc (CNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PSE Kinsale Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary PSE Kinsale Energy Ltd (Kinsale Energy), formerly Marathon Oil Ireland Limited, carries out the production and storage of natural gas from its facilities off the Old Head of Kinsale. The company operates Kinsale Head, Ballycotton, Seven Heads and Southwest Kinsale gas fields in the Celtic Se …
  • Lion Energy Ltd (LIO):企業の財務・戦略的SWOT分析
    Summary Lion Energy Ltd (Lion) is an oil and gas company that explores, develops and produces unconventional oil and gas resources in Indonesia. The company has conventional production sharing contracts such as Seram project and South Block A project. Its Seram project is located on the island of Se …
  • Leroy Seafood Group ASA:企業の戦略・SWOT・財務情報
    Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report Summary Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Seiko Epson Corporation:企業の戦略・SWOT・財務情報
    Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report Summary Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PTT Exploration and Production Public Co Ltd (PTTEP):企業の財務・戦略的SWOT分析
    PTT Exploration and Production Public Co Ltd (PTTEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • TDC AS:企業の戦略的SWOT分析
    TDC AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Kohl’s Corporation (KSS):企業の財務・戦略的SWOT分析
    Kohl's Corporation (KSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rabigh Refining & Petrochemical Co (2380):企業の財務・戦略的SWOT分析
    Rabigh Refining & Petrochemical Co (2380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Bionik Laboratories Corp (BNKL):企業の財務・戦略的SWOT分析
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company offers rehabilitation technology that senses patient movements and limitations. It provides lower body e …
  • Kongsberg Maritime AS-石油・ガス分野:企業M&A・提携分析
    Summary Kongsberg Maritime AS (Kongsberg Maritime), a subsidiary of Kongsberg Gruppen AS, is a provider of merchant marine, subsea and offshore solutions. The company offers a wide range of products that include bridge systems, camera systems, deck systems, engine room and automation systems, inform …
  • Konami Holdings Corp:企業の戦略・SWOT・財務情報
    Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Daisy Group PLC:企業のM&A・事業提携・投資動向
    Daisy Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daisy Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • The Providence Service Corporation:企業の戦略・SWOT・財務情報
    The Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary The Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • JSS Medical Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary JSS Medical Research Inc (JSS Medical Research) is a contract research organization that offers clinical research services. The organization provides clinical trial services in therapeutic areas such as oncology, infectious disease, cardiovascular disorders, psychiatry, neurology, respirator …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析2018
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Mesoblast Ltd (MSB):製薬・医療:M&Aディール及び事業提携情報
    Summary Mesoblast Ltd (Mesoblast) is a regenerative medicine company, which develops regenerative cell-based products. Its pipeline product candidates include MPC-150-IM, which is under development for the treatment of chronic congestive heart failure; MSC-100-IV, for the treatment of acute graft ve …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • bioMerieux SA (BIM):企業の財務・戦略的SWOT分析
    bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆